EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Multicenter Study on the Clinical Characteristics, Diagnosis, and Treatment Outcomes of Insulinoma: Insights From 15 Medical Centres

Şenay Topsakal iD, Güzin Fidan Yaylalı iD, Zeliha Yarar, Fatma Avcı Merdin, Seda Karslı, Sema Çiftçi, Mehmet Sercan Ertürk iD, Barış Önder Pamuk, Ayşe Özdemir Yavuz, Kader Uğur, Ogün Bilen, Sayid Shafi Zuhur und 13 weitere

Clinical Endocrinology · 2025-07 · 103 (1) · 57-65

DOI: 10.1111/cen.15255 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Endocrinology, online erschienen am 25.04.2025. Verfasst von Şenay Topsakal und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Faculty of Medicine, Pamukkale University, Denizli, Türkiye. Hauptthemen laut MEDLINE: Insulinoma, Pancreatic Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to evaluate the clinical characteristics, diagnostic approaches, and treatment outcomes of insulinoma patients from diverse regions across the country. We conducted a retrospective analysis of medical records from 76 adult patients diagnosed with insulinoma between 2018 and 2023 at 15 medical centres. Data collected included demographics, presenting symptoms, laboratory and imaging results, surgical reports, pathology findings, and clinical follow‐up information.

Design

Multi‐centre retrospective study.

Methods

The study revealed that key factors such as age, BMI, symptom duration, tumour size, and follow‐up period were similar across genders. The majority of patients experienced neuroglycopenic symptoms, particularly during fasting. Insulinoma was typically diagnosed either during fasting or spontaneously, with no significant gender differences in glucose and insulin levels during hypoglycemia. However, men exhibited higher C‐peptide levels ( p < 0.05). Common comorbidities included hypertension, hypothyroidism, and cardiovascular conditions, and some patients had been using antiepileptics or antidepressants before their diagnosis.

Results

Preoperative tumour diagnoses were largely accurate, with endoscopic ultrasound (EUS) being the most effective method. Most tumours were small ( < 2 cm) and located in the pancreas body, with the majority being solitary. Surgical treatments primarily involved enucleation or distal pancreatectomy. Follow‐up data indicated high remission rates, with low rates of nonremission and mortality.

Conclusion

This study emphasises that early diagnosis and intervention, particularly in patients with a history of neurological or psychiatric issues, postprandial symptoms, or rapid symptom improvement after treatment, can lead to significantly better outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InsulinomaPancreatic NeoplasmsHumansMaleFemaleRetrospective StudiesMiddle AgedAdultTreatment OutcomeAgedPancreatectomy

Stichwörter der Autor:innen

anthropometric parameterscomorbiditiesinsulinomamortalityprognosistreatment modalitiestumour behaviour

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Faculty of Medicine, Pamukkale University, Denizli, Türkiye.
  • Department of Endocrinology and Metabolism, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Türkiye.
  • Department of Endocrinology and Metabolism, Faculty of Medicine, Ankara University, Ankara, Türkiye.
  • Department of Endocrinology and Metabolism, Dr Sadi Konuk Training and Research Hospital, University Health Sciences, Istanbul, Türkiye.
  • Department of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Türkiye.
  • Department of Endocrinology and Metabolism, Turgut Özal Medical Center, İnönü University, Malatya, Türkiye.

ORCID-Profile: Şenay Topsakal, Güzin Fidan Yaylalı, Mehmet Sercan Ertürk

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Topsakal, Ş., Yaylalı, G. F., Yarar, Z., Merdin, F. A., Karslı, S., Çiftçi, S., Ertürk, M. S., Pamuk, B. Ö., Yavuz, A. Ö., Uğur, K., Bilen, O., Zuhur, S. S., Engin, İ., Güven, M., Cesur, F. M., Fakı, S., Polat, Ş. B., Çakır, B., Özışık, H., …, & Yarman, S. (2025). Multicenter Study on the Clinical Characteristics, Diagnosis, and Treatment Outcomes of Insulinoma: Insights From 15 Medical Centres. Clinical Endocrinology, 103(1), 57-65. https://doi.org/10.1111/cen.15255

Vancouver

Topsakal Ş, Yaylalı GF, Yarar Z, Merdin FA, Karslı S, Çiftçi S, et al. Multicenter Study on the Clinical Characteristics, Diagnosis, and Treatment Outcomes of Insulinoma: Insights From 15 Medical Centres. Clinical Endocrinology. 2025;103(1):57-65. doi:10.1111/cen.15255

BibTeX
@article{Topsakal2025,
  author = {Topsakal, Şenay and Yaylalı, Güzin Fidan and Yarar, Zeliha and Merdin, Fatma Avcı and Karslı, Seda and Çiftçi, Sema and Ertürk, Mehmet Sercan and Pamuk, Barış Önder and Yavuz, Ayşe Özdemir and Uğur, Kader and Bilen, Ogün and Zuhur, Sayid Shafi and Engin, İsmail and Güven, Mehmet and Cesur, Fazıl Mustafa and Fakı, Sevgül and Polat, Şefika Burçak and Çakır, Bekir and Özışık, Hatice and Kocabaş, Gökçen Ünal and Erdoğan, Mehmet and Çetinkalp, Şevki and Koçar, İlkcan Çerçi and Akbay, Esen and Yarman, Sema},
  title = {Multicenter Study on the Clinical Characteristics, Diagnosis, and Treatment Outcomes of Insulinoma: Insights From 15 Medical Centres},
  journal = {Clinical Endocrinology},
  year = {2025},
  volume = {103},
  number = {1},
  pages = {57--65},
  doi = {10.1111/cen.15255}
}
Kostenlos starten →